Earlier quoted context omitted.
> And if the law doesn't allow it, but the regulators never drop the hammer, don't expect people not to do it. I'm not saying it isn't fraud. I'm saying that its par for the course when regulators rarely take action. Mylan got greedy and got slapped. Regulatory bodies in the US are woefully underfunded and this sort of thing is the result. Blame congress.
64% of murders currently result in an conviction. At what percentage would it no longer be the perpetrators responsibility for the crime and instead be the fault of the lawmakers lack of ability to bring him to justice?
Mylan to Settle EpiPen Overpricing Case for $465M
31–40 of 85 posts
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#32Earlier quoted context omitted.
It's not a monopoly. There have been and continue to be other epinephrine auto-injectors from competitors.
Have been, but what else is on the market right now in the US? Why is that? Its not for lack of demand.
EpiPen® Auto-injector 0.3 mg (delivering a single dose of adrenaline 300 micrograms), adrenaline 1 mg/mL (1 in 1000), net price:
2-mL auto-injector device = £26.45
2 × 2-mL auto-injector device = £52.90
This is the same product from the same vendor as in the US.
[1] https://www.justproxy.co.uk/index.php?q=aHR0cDovL3d3dy5ldmlk...
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#33For people using the word "fraud." Fraud requires some misrepresentation of a material fact. Nobody at CMS was unaware of what an Epipen was, depending on Mylan's representations about what was in there. This is a fight over whether Mylan should have checked Box A or Box B. There is a reasonable case to be made for both sides. After all, the drug in an Epipen (epinephrine) is generic. For people talking about throwin…
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#34Earlier quoted context omitted.
> And if the law doesn't allow it, but the regulators never drop the hammer, don't expect people not to do it. I'm not saying it isn't fraud. I'm saying that its par for the course when regulators rarely take action. Mylan got greedy and got slapped. Regulatory bodies in the US are woefully underfunded and this sort of thing is the result. Blame congress.
64% of murders currently result in an conviction. At what percentage would it no longer be the perpetrators responsibility for the crime and instead be the fault of the lawmakers lack of ability to bring him to justice?
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#35Re: Mylan to Settle EpiPen Overpricing Case for $465M
#36Earlier quoted context omitted.
But how many fractions of a percent of their revenue does this really represent?
I'm not sure about revenue, but it represents about 55% of their annual profits. 465M / (EPS of 1.57 * 534.91M shares) = .5537
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#37It's like a game of musical chairs for who gets to pay the government a billion dollars this year.
This Epipen case sounds far less bad then most on that list. Especially if we're going to talk about punishment. As most of the other settlements on the list were for mislabeled drugs. People were spending money and wasted weeks/months of their supposed treatment on drugs that didn't help them.
I personally experienced the effects of this due to a bad doctor, not mislabeling, and I was seriously sick for a much longer period of time then I should have been. Fortunately I found a specialist who knew what he was talking about and told me to take one drug which cost $100/m instead of three others costing me $900/m (I didn't have drug benefits insurance at the time). For me the wasted time on a treatment that didn't work was far more harmful to me than the added cost.
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#38Earlier quoted context omitted.
It's not a monopoly. There have been and continue to be other epinephrine auto-injectors from competitors.
Have been, but what else is on the market right now in the US? Why is that? Its not for lack of demand.
Thorough explanation and editorilizing here: http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-dr...
Re: Mylan to Settle EpiPen Overpricing Case for $465M
#39Re: Mylan to Settle EpiPen Overpricing Case for $465M
#40Earlier quoted context omitted.
What would this accomplish?
It's tongue and cheek deterrent, it's effectively ex-communcaiton from their social circles which is where they get their attaboy/girl encouragement that this is acceptable behaviour. They don't see themselves as part of the hoi polloi, and bending the rules to their advantage is called "smart".
It's an unusual idea, and frankly it's cruel on the rest of us that we would have to share the same space as these people.